Chronic Use of Proton Pump Inhibitors Is Associated With Reduced 30‐Day Mortality From Acute Pancreatitis
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Maya Fischman, Adi Elias, Amir Klein, Yaron Cohen, Zaher S. Azzam, Itai Ghersin |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Editorial: Proton Pump Inhibitors and the Changing Face of Spontaneous Bacterial Peritonitis
por: S. Quickert, et al.
Publicado: (2026)
por: S. Quickert, et al.
Publicado: (2026)
Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors
por: Philip Kitchen, et al.
Publicado: (2026)
por: Philip Kitchen, et al.
Publicado: (2026)
Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor
por: Kee Huat Chuah, et al.
Publicado: (2024)
por: Kee Huat Chuah, et al.
Publicado: (2024)
Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor
por: Shoko Miyahara, et al.
Publicado: (2025)
por: Shoko Miyahara, et al.
Publicado: (2025)
Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor: Authors' Reply
por: Kee Huat Chuah, et al.
Publicado: (2025)
por: Kee Huat Chuah, et al.
Publicado: (2025)
MELD 3.0 Improves Risk Stratification and Mortality Prediction in Hepatorenal Syndrome‐Acute Kidney Injury: A Multicentre Study
por: Jing Ma, et al.
Publicado: (2025)
por: Jing Ma, et al.
Publicado: (2025)
Letter: Assessing the Durability of Treatment Effects: Long‐Term Outcomes of ESWL and ERCP for Pancreatic Duct Stones in Chronic Pancreatitis
por: Wei‐Zhen Tang, et al.
Publicado: (2024)
por: Wei‐Zhen Tang, et al.
Publicado: (2024)
Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues
por: Tyng‐Yuan Jang, et al.
Publicado: (2025)
por: Tyng‐Yuan Jang, et al.
Publicado: (2025)
Patient Plasma‐Induced Neutrophil Dysfunction Is Associated With Infection Risk and Mortality in Patients With Acute Decompensation of Cirrhosis
por: Supachaya Sriphoosanaphan, et al.
Publicado: (2025)
por: Supachaya Sriphoosanaphan, et al.
Publicado: (2025)
Editorial: Decoding ACLF—Sub‐Phenotyping to Advance Precision Medicine in Acute‐On‐Chronic Liver Failure
por: Amy Sangam, et al.
Publicado: (2024)
por: Amy Sangam, et al.
Publicado: (2024)
Statin Therapy Independently Reduces Mortality and Liver Complications in Patients With Cirrhosis: An Updated Systematic Review and Meta‐Analysis
por: Bernardo de Faria Moraes, et al.
Publicado: (2026)
por: Bernardo de Faria Moraes, et al.
Publicado: (2026)
Letter: The Essential Role of Social Workers in Reducing Socioeconomic Disparities in Chronic Liver Disease
por: Qiong Yi, et al.
Publicado: (2024)
por: Qiong Yi, et al.
Publicado: (2024)
Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease
por: Derek D. Satre, et al.
Publicado: (2024)
por: Derek D. Satre, et al.
Publicado: (2024)
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease‐Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute‐on‐Chronic Liver Failure and Death
por: Mathias Jachs, et al.
Publicado: (2025)
por: Mathias Jachs, et al.
Publicado: (2025)
Robust Predictive Performance of the SALT‐M Score for Clinical Outcomes in Asian Patients With Acute‐on‐Chronic Liver Failure
por: Kunhee Kim, et al.
Publicado: (2024)
por: Kunhee Kim, et al.
Publicado: (2024)
Mortality of Acute Kidney Injury in Cirrhosis: A Systematic Review and Meta‐Analysis of Over 5 Million Patients Across Different Clinical Settings
por: Vasileios Lekakis, et al.
Publicado: (2024)
por: Vasileios Lekakis, et al.
Publicado: (2024)
Letter: The Essential Role of Social Workers in Reducing Socioeconomic Disparities in Chronic Liver Disease—Author's Reply
por: Eunice Yewon Lee, et al.
Publicado: (2024)
por: Eunice Yewon Lee, et al.
Publicado: (2024)
Effect of Nucleos(t)ide Analogues Withdrawal on Survival Outcomes in Patients With Hepatitis B Virus‐Related Acute‐on‐Chronic Liver Failure
por: Yanxue Lin, et al.
Publicado: (2025)
por: Yanxue Lin, et al.
Publicado: (2025)
Timely Follow‐Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population‐Based Cohort of 8852 Patients
por: Max S. Schechter, et al.
Publicado: (2024)
por: Max S. Schechter, et al.
Publicado: (2024)
Editorial: Gene Silencing Therapy for a New Era of Pancreatitis Prevention
por: Maxim S. Petrov
Publicado: (2026)
por: Maxim S. Petrov
Publicado: (2026)
Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute Decompensation
por: Lucie Simonis, et al.
Publicado: (2025)
por: Lucie Simonis, et al.
Publicado: (2025)
Amino Acid Imbalance Is an Independent Factor for Mortality in Patients With Liver Cirrhosis
por: Yuki Utakata, et al.
Publicado: (2026)
por: Yuki Utakata, et al.
Publicado: (2026)
Editorial: Mortality in immune‐mediated inflammatory diseases during early adulthood
por: Paul Henderson
Publicado: (2024)
por: Paul Henderson
Publicado: (2024)
Letter: Toward Intra‐Class Switching With JAK Inhibitors?
por: Mathieu Uzzan, et al.
Publicado: (2025)
por: Mathieu Uzzan, et al.
Publicado: (2025)
Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis
por: Mushfiqur R. Siddique, et al.
Publicado: (2025)
por: Mushfiqur R. Siddique, et al.
Publicado: (2025)
Letter: Amino Acid Imbalance Is an Independent Factor for Mortality in Patients With Liver Cirrhosis
por: Zhanbo Qu
Publicado: (2026)
por: Zhanbo Qu
Publicado: (2026)
Editorial: Mortality in immune‐mediated inflammatory diseases during early adulthood—Authors' reply
por: Mikkel Malham, et al.
Publicado: (2024)
por: Mikkel Malham, et al.
Publicado: (2024)
Letter: Amino Acid Imbalance and Mortality in Cirrhosis—Interpretation and Methodological Considerations. Authors' Reply
por: Yuki Utakata, et al.
Publicado: (2026)
por: Yuki Utakata, et al.
Publicado: (2026)
Letter: Toward Intra‐Class Switching With JAK Inhibitors? Authors' Reply
por: Shintaro Akiyama, et al.
Publicado: (2025)
por: Shintaro Akiyama, et al.
Publicado: (2025)
Editorial: Checkpoint Inhibitor‐Induced Liver Injury—Time to Abandon CTCAE?
por: Kelly Torosian, et al.
Publicado: (2024)
por: Kelly Torosian, et al.
Publicado: (2024)
Letter: Refining Mortality Estimates in Severe Alcohol‐Associated Hepatitis—Addressing Heterogeneity and Prognostic Assessment
por: Shupeng Zhao, et al.
Publicado: (2025)
por: Shupeng Zhao, et al.
Publicado: (2025)
Meta‐Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease
por: Soroor Owrangi, et al.
Publicado: (2024)
por: Soroor Owrangi, et al.
Publicado: (2024)
Letter on ‘Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis’—Authors' Reply
por: Francisco Idalsoaga, et al.
Publicado: (2025)
por: Francisco Idalsoaga, et al.
Publicado: (2025)
Persistent Binge Drinking History Associated With Advanced Liver Fibrosis and All‐Cause Mortality in MetALD
por: Zhe‐Kun Xiong, et al.
Publicado: (2025)
por: Zhe‐Kun Xiong, et al.
Publicado: (2025)
Editorial: Immune Checkpoint Inhibitors and HBV Reactivation in Liver Cancer—Reassurance With Vigilance
por: Romeo Kuo‐Cheng Wu, et al.
Publicado: (2025)
por: Romeo Kuo‐Cheng Wu, et al.
Publicado: (2025)
Letter: The Prognostic Role of IGF‐1 in Chronic Liver Disease
por: Muhammad Osama, et al.
Publicado: (2024)
por: Muhammad Osama, et al.
Publicado: (2024)
Editorial: The Impact of Socioeconomic and Ethnic Factors on Chronic Liver Disease
por: Wah Loong Chan, et al.
Publicado: (2024)
por: Wah Loong Chan, et al.
Publicado: (2024)
Spontaneous Bacterial Peritonitis Is Associated With High Mortality, Which Interacts With Antibiotic Prophylaxis in a National Cirrhosis Cohort
por: Scott Silvey, et al.
Publicado: (2025)
por: Scott Silvey, et al.
Publicado: (2025)
Social Determinants of Health in Metabolic Dysfunction‐Associated Steatotic Liver Disease and All‐Cause/Cause‐Specific Mortality
por: Donghee Kim, et al.
Publicado: (2025)
por: Donghee Kim, et al.
Publicado: (2025)
Research Communication: Effects of Screening Colonoscopy on Colorectal Cancer Mortality: Lessons From Comparative Analyses of Randomised Trials
por: Hermann Brenner, et al.
Publicado: (2025)
por: Hermann Brenner, et al.
Publicado: (2025)
Ejemplares similares
-
Editorial: Proton Pump Inhibitors and the Changing Face of Spontaneous Bacterial Peritonitis
por: S. Quickert, et al.
Publicado: (2026) -
Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors
por: Philip Kitchen, et al.
Publicado: (2026) -
Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor
por: Kee Huat Chuah, et al.
Publicado: (2024) -
Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor
por: Shoko Miyahara, et al.
Publicado: (2025) -
Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor: Authors' Reply
por: Kee Huat Chuah, et al.
Publicado: (2025)